StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Suxamethoniumchlorid

Succinylcholine Chloride

HCID 22475
Neue Reaktion
Drucken
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
71-27-2
Standard-SMILES
C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C.[Cl-].[Cl-]
InChIKey
YOEWQQVKRJEPAE-UHFFFAOYSA-L
Summenformel
C14H30N2O4.2Cl
Durchschnittliche Molmasse
361,3 g/mol
Monoisotopische Masse
360,1582628

Überblick

Suxamethonium dichloride is a fine white powder. (NTP, 1992)

Namen und Bezeichner

Bevorzugter Name
Succinylcholine Chloride
IUPAC
trimethyl-[2-[4-oxo-4-[2-(trimethylazaniumyl)ethoxy]butanoyl]oxyethyl]azanium dichloride
Lokaler Name
Suxamethoniumchlorid
Englischer Name
Succinylcholine Chloride
Summenformel
C14H30Cl2N2O4
Molmasse
361.3

Namen und Synonyme

Succinylcholine chloride71-27-2Succinyldicholine chlorideAnectineMidarineScolineAnectine chlorideSuxamethonii chloridumLysthenoneMyopleginePantolaxSucostrin
Weitere Namen anzeigen
SUXAMETHONIUM CHLORIDEDITILINskolinLYSTHENONSUCCICURAN
SukolinSuxinylSuccinyl-astaScoline chlorideCloruro de suxametonioQuelicin chlorideSucostrin chlorideChlorsuccinylcholin

Datenbank-Bezeichner

CAS
71-27-2
PubChem CID
22475
DTXSID
DTXSID1023603
ChEMBL
CHEMBL983
ChEBI
CHEBI:61219
UNII
I9L0DDD30I
EC Number
200-747-4

Eigenschaften

Berechnete Struktureigenschaften

Polarare Oberfläche (TPSA)
52,6 Ų
H-Brücken-Donoren
0
H-Brücken-Akzeptoren
6
Frei drehbare Bindungen
11
Schwere Atome
22
Formalladung
0
Komplexität
284

Experimentelle und physikochemische Eigenschaften

Solubilitygreater than or equal to 100 mg/mL at 68 °F (NTP, 1992)
Human Drugs · 2 Einträge

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Melting Point313 to 325 °F (NTP, 1992)
Physical DescriptionSuxamethonium dichloride is a fine white powder. (NTP, 1992)

Physikochemische Eigenschaften

Schmelzpunkt
164 °C · 164 °C
storage temp.
Refrigerator
Löslichkeit
Methanol (Slightly), Water (Slightly)
Aggregatzustand
Solid
Farbe
White to Off-White
Merck
8875 · 8875
Stabilität
Stable. Combustible. Incompatible with strong oxidizing agents.
CAS Datenbank
71 · 71-27-2(CAS DataBase Reference)

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 4 Einträge

Danger

H301 (93.1%): Toxic if swallowed [Danger Acute toxicity, oral]

P261, P262, P264, P264+P265, P270, P271, P280, P301+P316, P302+P352, P304+P340, P305+P351+P338, P316, P317, P319, P321, P330, P332+P317, P337+P317, P361+P364, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 29 reports by companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Other Safety InformationIMAP assessments - Ethanaminium, 2,2'-[(1,4-dioxo-1,4-butanediyl)bis(oxy)]bis[N,N,N-trimethyl-, dichloride: Environment tier I assessment
DOT LabelPoison
Fire HazardsFlash point data for this chemical are not available. It is probably combustible. (NTP, 1992)
Health HazardsSYMPTOMS: Symptoms of exposure to this compound may include relaxation of skeletal muscles, particularly those of the abdominal wall.
Reactive GroupEsters, Sulfate Esters, Phosphate Esters, Thiophosphate Esters, and Borate Esters
Air and Water ReactionsWater soluble.
Hazard Classes and CategoriesAcute Tox. 3 (93.1%)

Sicherheit und Schutzausrüstung

Chemie und Industrie

Pharmakologische Informationen

FDA Pharmacological Classification · 2 Einträge

SUCCINYLCHOLINE CHLORIDE

Depolarizing Neuromuscular Blocker [EPC]; Neuromuscular Depolarizing Blockade [PE]

MeSH Pharmacological ClassificationDrugs that interrupt transmission at the skeletal neuromuscular junction by causing sustained depolarization of the motor end plate. These agents are primarily used as adjuvants in surgical anesthesia to cause skeletal muscle relaxation.
Anwendungen · 2 Einträge

BeschreibungSuccinylcholine chloride is a potent relaxant of voluntary striated muscle but has little direct effect on smooth muscle. It has no anesthetic or pain-obliterating properties; therefore, immobilized animals remain completely conscious although unable to move. The duration of effect is quite brief because succinylcholine is rapidly destroyed by non-specific cholinesterases in the blood plasma and liver. Immobilization lasts five to 12 minutes in man and horses and somewhat longer in other species,with ruminants generally requiring longest recovery periods (Stowe et al. 1958).Since the discovery of its curariform properties in 1949, succinylcholine has been widely used for immobilization of animals and in human surgical procedures. Several workers have used succinylcholine on bears (Black 1958, Knudsen 1959, Craighead et al. 1960, Troyer et al. 1961,Hornocker 1962, Mundy 1963,Pearson et al. 1968, Jonkel and Cowan 1971 and Mundy and Flook 1973).Succinylcholine chloride is indicated as an adjunct to general anesthesia, to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation.

VerwendenA neuromuscular blocking agent. Muscle relaxant (skeletal).

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

ChlormethanNatriumhydroxid

Zugehörige Reaktionen

0
Reaktionsaufzeichnung erstellen
Noch keine zugehörigen Reaktionen

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
EPA chemische Informationen
Succinylcholine chloride (71-27-2)
Fire FightingFires involving this material can be controlled with a dry chemical, carbon dioxide or Halon extinguisher. (NTP, 1992)
First Aid · 1 Eintrag

EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.

Nonfire Spill Response · 1 Eintrag

SMALL SPILLS AND LEAKAGE: If you spill this chemical, you should dampen the solid spill material with water, then transfer the dampened material to a suitable container. Use absorbent paper dampened with water to pick up any remaining material. Seal your contaminated clothing and the absorbent paper in a vapor-tight plastic bag for eventual disposal. Wash all contaminated surfaces with a soap and water solution. Do not reenter the contaminated area until the Safety Officer (or other responsible person) has verified that the area has been properly cleaned.

Isolation and EvacuationExcerpt from ERG Guide 151 [Substances - Toxic (Non-Combustible)]:
Personal Protective Equipment (PPE) · 1 Eintrag

RECOMMENDED RESPIRATOR: Where the neat test chemical is weighed and diluted, wear a NIOSH-approved half face respirator equipped with a combination filter cartridge, i.e. organic vapor/acid gas/HEPA (specific for organic vapors, HCl, acid gas, SO2 and a high efficiency particulate filter). (NTP, 1992)

Toxikologische Informationen

Adverse Effects · 1 Eintrag

Hyperkalemia is the most common adverse effect of succinylcholine administration, attributed to the drug's stimulatory effect on skeletal muscles. Serum potassium levels may increase as much as 0.5 mEq/L, which is clinically insignificant unless a predisposition to hyperkalemia exists as a result of disease pathophysiology that induces upregulation of postjunctional acetylcholine receptors. Succinylcholine is contraindicated for patients with these conditions. If hyperkalemia is sufficient to create electrocardiography changes, clinicians should avoid using succinylcholine in such circumstances. Special consideration is also necessary for those with chronically elevated potassium levels, such as renal failure patients, to not induce acute on chronic hyperkalemia. Succinylcholine should be avoided in patients with significant burns or traumatic injuries that are 24 to 72 hours post-injury due to the high probability of acute hyperkalemia that may become exacerbated as a result. Marked or untreated hyperkalemia may result in dysrhythmias or even death.

Toxicity SummarySigns and Symptoms of Overdose
Drug Induced Liver Injury · 6 Einträge

Drug Induced Liver Injury Rank (DILIrank 2.0)

Succinylcholine chloride

vNo-DILI-concern

0

No match

DOI:10.1016/j.drudis.2016.02.015

Sicherheitsdaten

ridadr
3249
RTECS-Nr.
GA2360000
Toxizität
LD50 i.v. in mice: 0.45 mg/kg (Anttila, Ertama)
safety_code
7/8
hazard_class
6.1(b)
packing_group
III
Butanedioic acid, 1,4-bis(2-nitrophenyl) ester
Butanedioic acid, 1,4-bis(4-nitrophenyl) ester
Butanedioic acid,1,4-bis(2-chloroethyl) ester
Bis[2-(dimethylamino)ethyl]succinat

Ergänzende Hinweise

DefinitionChEBI: A chloride salt in which the negative charge of the chloride ions is balanced by succinylcholine dications.